BioAmber announces its first succinic acid take-or-pay contract with PTTMCC

Earlier this month, BioAmber announced the signing of its first take-or-pay contract for succinic acid with PTTMCC, a joint venture (JV) between Mitsubishi Chemical Corporation and PTT Public Company Limited. PTTMCC will convert the succinic acid to polybutylene succinate (PBS) in the PBS plant t...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email Thank you!

Related Research

Braskem is investing $61 million to expand bio-based ethylene capacity to 260 ktpa

News Commentary | March 02, 2021

This announcement is considered a delay of plans, as the company initially intended to double its capacity after a few years of production over a decade ago. The delay results from the slow‑growing demand for Braskem's materials, as their higher costs have limited their use to niche products. Brands... Not part of subscription

LCY Biosciences putting BioAmber's assets to use in Sarnia and planning to ramp up operations

News Commentary | August 30, 2021

This announcement is the first piece of positive news for the succinic acid space in years. In late 2018, LCY acquired the Sarnia plant and said it would continue BioAmber's legacy and produce succinic acid, at least in the short run. Today, the company is producing 18,000 metric tons of succinic ... Not part of subscription

Låkril Technologies

Company Snapshot | February 11, 2022

The company was founded by Christopher Nicholas and Paul Dauenhauer in 2021; Paul is a chemical engineer with experience developing technologies to convert biomass into various chemical building blocks, and Chris has over 15 years of experience in developing and scaling catalysts, catalytic ... Not part of subscription